By Sean O’Malley, Senior Writer
CAMH Senior Scientist Dr. Daisy Singla has devoted her entire career to one goal: improving access to mental health carefor pregnant women and new mothers.
In 2018, Dr. Singla became the youngest recipient of a $13-million-USD award to conduct a five-year clinical trial known as SUMMIT (Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment) funded by the Patient-Centered Outcomes Research Institute in the United States. The study is implemented at three sites across Toronto (led by Drs. Singla, Simone Vigod, and Cindy-Lee Dennis), as well as Chapel Hill (led by Dr. Samantha Meltzer-Brody) and Chicago (led by Dr. Richard Silver) in the U.S.
Talk therapies are amongst the most effective interventions in medicine but remain inaccessible to many. Around the world, as few as one in five women can access effective treatment for anxiety and depression during pregnancy and postpartum due to a dearth of available specialists, and high costs, transportation and childcare. When women don’t receive treatment for these conditions, the ripple effects can be devastating for them, their children, their partners and their communities.